12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Ensysce Biosciences (ENSC), Outlook Therapeutics (OTLK), INVO Bioscience (INVO), Kronos Bio (KRON), vTv Therapeutics (VTVT), and Pluri (PLUR) saw their shares rise by 11.03% to 28.1%. Conversely, Inovio Pharmaceuticals (INO), Venus Concept (VERO), Panbela Therapeutics (PBLA), Aclarion (ACON), Renalytix (RNLX), and Aravive (ARAV) witnessed declines ranging from 11.76% to 20.5%.
January 23, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ensysce Biosciences stock rose by 28.1% to $1.46 in pre-market trading with a market cap of $4.5 million.
The significant pre-market rise in ENSC's stock price suggests positive investor sentiment which could lead to a short-term upward price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
INVO Bioscience shares rose by 23.3% to $1.27, with a market cap of $3.1 million.
INVO's notable pre-market increase may lead to continued investor interest and a potential short-term uptrend in its stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Kronos Bio shares climbed 18.69% to $1.27, with a market cap of $74.0 million.
The pre-market rise in KRON's stock price could be indicative of a bullish sentiment that might persist in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Outlook Therapeutics shares increased by 23.52% to $0.42, with a market cap of $109.3 million.
The substantial pre-market gain for OTLK indicates strong investor interest, which may translate into a short-term positive trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Pluri stock rose by 11.03% to $0.63, with a market cap of $26.2 million.
The increase in PLUR's stock price during pre-market trading may attract more investors, potentially leading to a short-term positive price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
vTv Therapeutics shares increased by 16.2% to $11.2, with a market cap of $22.8 million.
The pre-market gain for VTVT suggests a positive investor outlook, potentially leading to a short-term uptrend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Aclarion stock dropped by 11.88% to $2.3, with a market cap of $1.9 million.
Aclarion's stock price decrease in pre-market trading may lead to a negative short-term trend if the sentiment persists.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Aravive stock fell by 11.76% to $0.04, with a market cap of $3.1 million.
Aravive's stock price decline during pre-market hours could be a sign of negative investor sentiment, possibly leading to further short-term depreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Inovio Pharmaceuticals shares fell by 20.5% to $0.55, with a market cap of $150.1 million.
The significant pre-market decline in INO's stock price could reflect negative sentiment, likely leading to a short-term downtrend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Panbela Therapeutics shares decreased by 17.06% to $3.6, with a market cap of $1.7 million.
Panbela Therapeutics' pre-market decline could indicate a negative outlook from investors, potentially leading to further short-term losses.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Renalytix shares dropped by 11.84% to $0.26, with a market cap of $13.2 million.
The pre-market decline for RNLX may suggest investor skepticism, potentially leading to a downward trend in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Venus Concept shares fell by 17.56% to $1.08, with a market cap of $5.9 million.
The pre-market drop in VERO's stock price suggests bearish investor sentiment, which may continue into the short-term market session.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90